Optimal Intervention in Markovian Gene Regulatory Networks With Random-Length Therapeutic Response to Antitumor Drug.
Overview
Research
Identity
Additional Document Info
Other
View All
Overview
abstract
The most effective cancer treatments are the ones that prolong patients' lives while offering a reasonable quality of life during and after treatment. The treatments must also carry out their actions rapidly and with high efficiency such that a very large percentage of tumor cells die or shift into a state where they stop proliferating. Due to biological and microenvironmental variabilities within tumor cells, the action period of an administered drug can vary among a population of patients. In this paper, based on a recently proposed model for tumor growth inhibition, we first probabilistically characterize the variability of the length of drug action. Then, we present a methodology to devise optimal intervention strategies for any Markovian genetic regulatory network governing the tumor when the antitumor drug has a random-length duration of action.